Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide
2007

Imatinib's Effect on Etoposide and Ifosfamide in Cancer Treatment

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Rezaï Keyvan, Lokiec François, Grandjean Isabelle, Weill Sophie, de Cremoux Patricia, Bordier Vincent, Ekue Richard, Garcia Mickael, Poupon Marie-France, Decaudin Didier

Primary Institution: Institut Curie, Paris, France

Hypothesis

Does imatinib enhance the pharmacokinetics and efficacy of etoposide and ifosfamide in cancer treatment?

Conclusion

Imatinib increases the effectiveness of etoposide in certain cancers, justifying further clinical trials.

Supporting Evidence

  • Imatinib increased the AUC of etoposide in mice.
  • Concomitant administration of imatinib and etoposide enhanced tumor growth inhibition in lymphoma models.
  • Imatinib did not significantly affect the urinary excretion of etoposide.

Takeaway

Imatinib helps make cancer drugs like etoposide work better, which could help people with certain types of cancer.

Methodology

The study used human tumor xenografts in mice to evaluate the effects of imatinib on chemotherapy.

Limitations

The study was conducted in mice, which may not fully represent human responses.

Participant Demographics

Female nude or SCID mice, 6–8 weeks old.

Statistical Information

P-Value

0.025

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2210-7-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication